SSII Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SSII is not a good buy right now. Price action and trend signals are decisively bearish (downtrend across moving averages with worsening MACD), and there are no Intellectia buy signals to justify an impatient entry. Without a clear catalyst or sentiment tailwind, the higher-probability move is continued weakness/volatility rather than an immediate rebound worth buying.
Trend/structure: Bearish. The moving-average stack is SMA_200 > SMA_20 > SMA_5, signaling a sustained downtrend with weak short-term momentum. Momentum: MACD histogram at -0.126 is below zero and negatively expanding, indicating downside momentum is strengthening rather than stabilizing. RSI: RSI_6 at 24.53 is effectively oversold (despite the provided label saying “neutral”), which can allow for short bounces, but oversold alone is not a buy signal when MACD and MAs keep deteriorating. Levels: Current price ~4.20 is below S1 (4.338) and well below the pivot (5.059). That means prior support has been lost; the stock would need to reclaim at least ~4.34 and then ~5.06 to improve the technical picture. Resistance sits at ~5.78 (R1). Pattern-based short-term odds: Similar-candlestick model suggests modest upside next day (+1.1% chance) but weakness over the next week (-1.92%), with a possible rebound over a month (+5.87%). Given the strong bearish trend signals, the weekly weakness risk dominates for an impatient entry.
Intellectia Proprietary Trading Signals
2025/Q3 revenue surged to 12,829,349 (+276.37% YoY), and gross margin improved to 45.74 (up sharply YoY), showing strong top-line expansion and better unit economics. The candlestick-similarity model also points to potential 1-month upside (+5.87%).
and below the pivot (5.059). Profitability remains weak: net income is still negative (-3,717,
with EPS at -0.02 (worse YoY). No news catalysts in the last week, and hedge fund/insider activity is neutral (no supportive flow signal). No recent congress trading data available.
Latest quarter: 2025/Q3. Revenue increased to 12,829,349 (+276.37% YoY), indicating rapid growth. However, earnings quality is still weak: net income fell to -3,717,964 (more negative YoY by the provided metric), and EPS dropped to -0.02 (-50% YoY). Gross margin improved to 45.74, suggesting better margins, but the company has not translated that into profitability yet.
No analyst rating or price target change data was provided, so there is no clear Wall Street consensus trend to lean on. With no published pro/con view available here, the decision relies mainly on the bearish technicals versus improving revenue/margins—currently the technicals dominate for a buy-today decision.
